102830-49-9 Usage
Uses
Used in Pharmaceutical Research:
BOC-D-CYS(BZL)-OH is used as a precursor in the synthesis of peptides for pharmaceutical applications. Its role is crucial in the development of new drugs and therapies, as it contributes to the formation of complex molecular structures that can target specific biological processes.
Used in Scientific Research:
In the field of scientific research, BOC-D-CYS(BZL)-OH is employed as a building block for creating intricate molecular constructs. Its presence in peptide synthesis allows for the exploration of novel chemical interactions and the potential discovery of new biological functions.
Used in Drug Development:
BOC-D-CYS(BZL)-OH is used as a key component in drug development, where its protective groups facilitate the synthesis of peptides with desired properties. The removal of the BOC group in later stages of the process enables the compound to participate in crucial biological activities, making it an essential tool in the creation of effective treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 102830-49-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,8,3 and 0 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 102830-49:
(8*1)+(7*0)+(6*2)+(5*8)+(4*3)+(3*0)+(2*4)+(1*9)=89
89 % 10 = 9
So 102830-49-9 is a valid CAS Registry Number.
InChI:InChI=1/C15H21NO4S/c1-15(2,3)20-14(19)16-12(13(17)18)10-21-9-11-7-5-4-6-8-11/h4-8,12H,9-10H2,1-3H3,(H,16,19)(H,17,18)/t12-/m1/s1
102830-49-9Relevant academic research and scientific papers
Combination of non-natural D-amino acid derivatives and allophenylnorstatine-dimethylthioproline scaffold in HIV protease inhibitors have high efficacy in mutant HIV
Nakatani, Shingo,Hidaka, Koushi,Ami, Ei'Ichi,Nakahara, Koichiro,Sato, Akihiko,Nguyen, Jeffrey-Tri,Hamada, Yoshio,Hori, Yasuko,Ohnishi, Nobuyuki,Nagai, Akinori,Kimura, Tooru,Hayashi, Yoshio,Kiso, Yoshiaki
experimental part, p. 2992 - 3004 (2009/04/05)
Several non-natural D-amino acid derivatives were introduced as P2/P3 residues in allophenylnorstatine-containing (Apns; (2S,3S)-3-amino-2-hydroxy-4- phenylbutyric acid) HIV protease inhibitors. The synthetic analogues exhibited potent inhibitory activity
